Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
Author:
Funder
U.S. Public Health Service
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference66 articles.
1. Cancer Facts and Figures,2017
2. Cancer Facts & Figures,2018
3. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications;Erkan;Nat. Rev. Gastroenterol. Hepatol.,2012
4. Emerging therapeutic potential of nanoparticles in pancreatic cancer: a systematic review of clinical trials;Au;Biomedicine,2016
5. Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications;Ji;Adv. Mater.,2013
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-PD-L1 checkpoint inhibitor combined with nanocarrier-mediated cisplatin codelivery system for effective treatment of pancreatic cancer;Molecular Immunology;2024-10
2. Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems;Journal of Biochemical and Molecular Toxicology;2024-08
3. The efficacy of coaxial percutaneous iodine-125 seed implantation combined with arterial infusion chemotherapy for advanced pancreatic cancer: a randomized clinical trial;International Journal of Radiation Biology;2024-04-30
4. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor;Nano Today;2024-02
5. Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments;Pharmaceutics;2024-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3